Rankings
▼
Calendar
INSM Q3 2023 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$79M
+16.7% YoY
Gross Profit
$62M
78.9% margin
Operating Income
-$148M
-186.8% margin
Net Income
-$159M
-201.0% margin
EPS (Diluted)
$-1.11
QoQ Revenue Growth
+2.4%
Cash Flow
Operating Cash Flow
-$136M
Free Cash Flow
-$139M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$1.6B
Stockholders' Equity
-$289M
Cash & Equivalents
$487M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$79M
$68M
+16.7%
Gross Profit
$62M
$54M
+14.9%
Operating Income
-$148M
-$128M
-15.6%
Net Income
-$159M
-$131M
-21.2%
Geographic Segments
UNITED STATES
$59M
75%
JAPAN
$16M
20%
Europe And The Rest Of The World
$4M
5%
← FY 2023
All Quarters
Q4 2023 →